Jaime E. Hernández

1.7k total citations
38 papers, 1.1k citations indexed

About

Jaime E. Hernández is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Jaime E. Hernández has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 16 papers in Virology and 10 papers in Emergency Medicine. Recurrent topics in Jaime E. Hernández's work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (16 papers) and HIV-related health complications and treatments (10 papers). Jaime E. Hernández is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (16 papers) and HIV-related health complications and treatments (10 papers). Jaime E. Hernández collaborates with scholars based in United States, Netherlands and Australia. Jaime E. Hernández's co-authors include Vanessa C. Williams, Grace A. McComsey, Robin L. Fisher, J Tyler Lonergan, Lisa Ross, Cindy Brothers, Peter Shalit, Michael Sension, Douglas Ward and Edwin DeJesus and has published in prestigious journals such as Clinical Infectious Diseases, Archives of Physical Medicine and Rehabilitation and AIDS.

In The Last Decade

Jaime E. Hernández

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jaime E. Hernández United States	15	721	531	472	262	72	38	1.1k
Herman G. Sprenger Netherlands	13	624 0.9×	391 0.7×	396 0.8×	223 0.9×	46 0.6×	41	994
Duncan Churchill United Kingdom	17	720 1.0×	543 1.0×	284 0.6×	241 0.9×	38 0.5×	50	1.1k
Tiziana Quirino Italy	22	841 1.2×	493 0.9×	557 1.2×	331 1.3×	47 0.7×	60	1.5k
Kathleen Squires United States	11	432 0.6×	325 0.6×	263 0.6×	267 1.0×	86 1.2×	17	817
David Dalmau Spain	21	970 1.3×	774 1.5×	333 0.7×	329 1.3×	56 0.8×	58	1.4k
Joseph G. Jemsek United States	11	945 1.3×	644 1.2×	246 0.5×	439 1.7×	70 1.0×	18	1.3k
M. A. Sambeat Spain	17	496 0.7×	422 0.8×	354 0.8×	295 1.1×	73 1.0×	24	879
Michèle Grappin France	17	624 0.9×	306 0.6×	384 0.8×	387 1.5×	68 0.9×	33	1.0k
Marielle Buisson France	18	492 0.7×	205 0.4×	256 0.5×	479 1.8×	31 0.4×	39	1.1k
Pierre de Truchis France	19	653 0.9×	582 1.1×	463 1.0×	276 1.1×	32 0.4×	42	1.1k

Countries citing papers authored by Jaime E. Hernández

Since Specialization

Citations

This map shows the geographic impact of Jaime E. Hernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime E. Hernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime E. Hernández more than expected).

Fields of papers citing papers by Jaime E. Hernández

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime E. Hernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime E. Hernández. The network helps show where Jaime E. Hernández may publish in the future.

Co-authorship network of co-authors of Jaime E. Hernández

This figure shows the co-authorship network connecting the top 25 collaborators of Jaime E. Hernández. A scholar is included among the top collaborators of Jaime E. Hernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime E. Hernández. Jaime E. Hernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Atiee, George, Kenneth C. Lasseter, Amy McCullough, et al.. (2011). Absence of Pharmacokinetic Interaction Between Intravenous Peramivir and Oral Oseltamivir or Rimantadine in Humans. The Journal of Clinical Pharmacology. 52(9). 1410–1419. 13 indexed citations

Hernández, Jaime E., J. Grainger, Lone Simonsen, et al.. (2011). Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment. Influenza and Other Respiratory Viruses. 6(5). 305–308. 8 indexed citations

Hernández, Jaime E., et al.. (2008). Study of the Effects of an Intervention to Reduce the Disproportionate Identification in the Category of Emotional Disturbance in the Los Angeles Unified School District.. 21(2). 64–74. 1 indexed citations

Hernández, Jaime E., Beth Harry, Lynn Newman, & Renée Cameto. (2008). Survey of Family Involvement in and Satisfaction with the Los Angeles Unified School District Special Education Processes.. 21(2). 84–93. 7 indexed citations

Hauber, Brett, Ateesha F. Mohamed, Maria Watson, F. Reed Johnson, & Jaime E. Hernández. (2008). Benefits, Risk, and Uncertainty: Preferences of Antiretroviral-Naïve African Americans for HIV Treatments. AIDS Patient Care and STDs. 23(1). 29–34. 29 indexed citations

Cherry, Catherine L., Luxshimi Lal, Katherine A. Thompson, et al.. (2005). Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudine.. PubMed. 38(3). 263–7. 35 indexed citations

Ross, Lisa, Ronan Boulmé, Jaime E. Hernández, et al.. (2005). A Direct Comparison of Drug Susceptibility to HIV Type 1 from Antiretroviral Experienced Subjects as Assessed by the Antivirogram and PhenoSense Assays and by Seven Resistance Algorithms. AIDS Research and Human Retroviruses. 21(11). 933–939. 16 indexed citations

Keiser, Philip, Michael Sension, Edwin DeJesus, et al.. (2005). Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment. BMC Infectious Diseases. 5(1). 2–2. 31 indexed citations

Lonergan, J Tyler, Grace A. McComsey, Robin L. Fisher, et al.. (2004). Lack of Recurrence of Hyperlactatemia in HIV-Infected Patients Switched From Stavudine to Abacavir or Zidovudine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(4). 935–942. 15 indexed citations

10.

DeJesus, Edwin, Eugénio Teófilo, Jan Gerstoft, et al.. (2004). Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults. Clinical Infectious Diseases. 39(7). 1038–1046. 175 indexed citations

11.

Considine, Robert V., Fred R. Sattler, Mark A. Deeg, et al.. (2004). Changes in Thrombolytic and Inflammatory Markers After Initiation of Indinavir- or Amprenavir-Based Antiretroviral Therapy. Cardiovascular Toxicology. 4(2). 179–168. 7 indexed citations

12.

McComsey, Grace A., J Tyler Lonergan, Charles L. Hoppel, et al.. (2004). Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS. 19(1). 15–23. 136 indexed citations

13.

Nadler, Jeffrey P., Joseph Gathe, Richard B. Pollard, et al.. (2003). Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients. BMC Infectious Diseases. 3(1). 10–10. 11 indexed citations

14.

Ross, Lisa, Anthony Scarsella, Keith Henry, et al.. (2001). Thymidine Analog and Multinucleoside Resistance Mutations Are Associated with Decreased Phenotypic Susceptibility to Stavudine in HIV Type 1 Isolated from Zidovudine-Naive Patients Experiencing Viremia on Stavudine-Containing Regimens. AIDS Research and Human Retroviruses. 17(12). 1107–1115. 29 indexed citations

15.

Rodrı́guez, Mario H., et al.. (2000). Different prevalences of Plasmodium vivax phenotypes VK210 and VK247 associated with the distribution of Anopheles albimanus and Anopheles pseudopunctipennis in Mexico.. American Journal of Tropical Medicine and Hygiene. 62(1). 122–127. 55 indexed citations

16.

Hernández, Jaime E., et al.. (1996). Nosocomial Infection Due to Vibrio cholerae in Two Referral Hospitals in Guatemala. Infection Control and Hospital Epidemiology. 17(6). 371–372. 4 indexed citations

17.

Arathoon, Eduardo, et al.. (1994). Serum HIV-1 p24 levels and body weight measurements before and after 4 weeks of diethylcarbamazine treatment given to HIV-1 seropositive persons. International Journal of Antimicrobial Agents. 3(4). 275–278. 2 indexed citations

18.

Kitchen, Lynn W., et al.. (1993). Effect of administration of diethylcarbamazine with and without fluconazole on experimental fungal infections in mice. International Journal of Antimicrobial Agents. 2(4). 237–246. 5 indexed citations

19.

Kitchen, Lynn W., et al.. (1992). Effect of administration of diethylcarbamazine on experimental bacterial and fungal infections in mice. International Journal of Antimicrobial Agents. 1(5-6). 259–267. 6 indexed citations

20.

Hernández, Jaime E.. (1991). El concepto del derecho en el joven Marx. Repositorio Institucional Zaloamati (Universidad Autónoma Metropolitana).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact